Tevogen Bio Holdings Inc.TVGNWEarnings & Financial Report
Nasdaq
TVGNW Q3 2025 Key Financial Metrics
Revenue
$-62.3K
Gross Profit
N/A
Operating Profit
$-5.7M
Net Profit
$-5.7M
Gross Margin
N/A
Operating Margin
9190.6%
Net Margin
9186.4%
YoY Growth
-400.4%
EPS
$-0.03
Tevogen Bio Holdings Inc. Q3 2025 Financial Summary
Tevogen Bio Holdings Inc. reported revenue of $-62.3K for Q3 2025, with a net profit of $-5.7M (9186.4% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $-62.3K |
|---|---|
| Net Profit | $-5.7M |
| Gross Margin | N/A |
| Operating Margin | 9190.6% |
| Report Period | Q3 2025 |
Tevogen Bio Holdings Inc. Annual Revenue by Year
Tevogen Bio Holdings Inc. annual revenue history includes year-by-year totals (for example, 2023 revenue was $-5.2M).
| Year | Annual Revenue |
|---|---|
| 2023 | $-5.2M |
Income Statement
| Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $-299887 | $-1.7M | $-1.4M | $0 | $6 | $-12459 | $-38033 | $-62340 |
| YoY Growth | N/A | N/A | N/A | N/A | 100.0% | 99.3% | -633983.3% | -400.4% |
Balance Sheet
| Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $26.4M | $26.4M | $17.0M | $3.4M | $3.3M | $4.3M | $4.3M | $4.5M |
| Liabilities | $16.2M | $16.6M | $17.7M | $9.2M | $10.9M | $10.5M | $13.8M | $12.3M |
| Equity | $-15.6M | $-16.2M | $-17.4M | $-5.8M | $-7.6M | $-6.2M | $-9.5M | $-7.8M |
Cash Flow
| Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q2 2025 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-397273 | $-208464 | $-693711 | $-2.2M | $-3.0M | $-3.8M | $-3.2M | $-3.6M |